Menopause changes the vaginal microbiome through a mechanism that is well understood, and its effect on the gut microbiome is far less settled. In the guides we publish here, this pairing comes up because two categories that used to be marketed separately are now sold together. Both claims deserve to be read differently, and most product pages present them as though they carry equal weight.
The vaginal change is part of routine menopause medicine. Estrogen supports glycogen in the vaginal lining, Lactobacillus species turn that glycogen into lactic acid, and the acid holds pH low. Less estrogen means less glycogen and fewer lactobacilli, so pH rises.
The gut side is genuine research with an unfinished middle. Gut bacteria do act on estrogen, and composition does differ between premenopausal and postmenopausal groups. Neither finding has yet produced a consumer test that tells one person what to do.
The Verdict
Five Claims, Sorted by Evidence
Product pages in this category mix well established biology with speculation, and the two are presented in the same typeface. The table separates them.
| Claim | Evidence state | The mechanism, or why it is unresolved | What a test can show |
|---|---|---|---|
| Falling estrogen changes the vaginal microbiome | Well established, and part of routine menopause medicine | Estrogen maintains glycogen in the vaginal lining. Lactobacillus species metabolise that glycogen into lactic acid, holding pH low. Less estrogen means less glycogen, fewer lactobacilli and a higher pH | A vaginal swab test can describe the shift. It cannot tell you whether your symptoms come from it |
| Gut bacteria influence how estrogen circulates | Established biochemistry, early clinical application | Some gut bacteria produce beta-glucuronidase, an enzyme that reverses the packaging the liver applies to estrogen before disposal. Reversed, the estrogen can be reabsorbed rather than excreted | A stool test can report bacterial composition. No consumer test converts that into a usable estrogen number |
| Gut bacterial composition differs before and after menopause | Observed in comparison studies, cause and direction unresolved | Postmenopausal and premenopausal groups differ in composition on average. Age, diet, medication and body composition all shift alongside menopause and are hard to separate | A test can place you against a reference population. Averages across groups do not transfer to one person |
| A microbiome test can guide menopause symptom management | Not supported | No published trial demonstrates that acting on a consumer microbiome report improves menopause symptoms compared with standard care | Nothing. This is where the marketing runs ahead of the evidence |
| Probiotics fix menopause-related microbiome change | Mixed and strain-specific | Trial results depend heavily on which strain, which dose and which symptom. Findings for one strain do not generalise to a different product on a shelf | A test cannot tell you which product would work for you. Strain-level evidence sits with each individual product |
Row three is the one that gets stretched furthest. A difference between two groups of women, on average, is a population finding. It does not transfer to an individual result, because the variation between two people in the same group is usually larger than the difference between the group averages.
A report placing you in a percentile against postmenopausal women is describing where you sit in a distribution, which is not the same as identifying something to change. Row one sits at the other end. The American College of Obstetricians and Gynecologists describes the thinning and drying of vaginal tissue after menopause in its own patient material, and the microbial shift travels with that tissue change.
What Each Test Returns
Four tests get sold against this topic and they measure different things. Reading the second and fourth columns together is the fastest way to see which one answers the question you have.
| Test | What it measures | What it is good for | What it cannot tell you |
|---|---|---|---|
| Stool microbiome sequencing | Bacterial species present in a stool sample, plus composition scores against a reference group | A description of your gut bacteria at one moment | Whether that composition is causing any symptom you have, and what would change it |
| Vaginal microbiome swab | Bacterial and fungal species in the vaginal tract, and whether Lactobacillus dominance is present | The clearest menopause-related microbiome signal available to consumers, because the underlying biology is understood | Whether your genitourinary symptoms are caused by the shift, which is a clinical assessment |
| Hormone panel | Estradiol, FSH, LH and often thyroid markers from a blood draw | Where you sit in the menopause transition, read alongside your cycle history and symptoms | Anything about bacteria. It measures hormones, not the microbiome |
| Dried urine hormone metabolite testing | Estrogen metabolites and their ratios across a collection window | A picture of how estrogen is being processed, which is closer to the estrobolome question than a stool test gets | Which bacteria are involved, and clinical thresholds are far less settled than for a blood panel |
The vaginal swab stands out for a reason worth stating plainly. Its underlying biology is understood, it has a measurable marker in Lactobacillus dominance, and the symptoms it relates to are ones clinicians already recognise and treat. Gut sequencing has none of those three properties for this question.
That gap is why we would put a swab and a hormone panel ahead of a stool kit for anyone whose starting point is menopause rather than digestion.
On the hormone side, our page on the perimenopause biomarker panel covers which blood markers are informative during the transition. It also covers which ones move too much cycle to cycle to be read from a single draw.
Where Sample Handling Undermines the Result
A microbiome sample keeps changing after you collect it, so what reaches the laboratory is not always what left your bathroom. Bacterial populations shift with temperature and time in transit, and some species survive the journey better than others. Sequencing cannot correct for this, because the instrument reads what it is given.
This is the part of the category where the differences between providers are real and testable, and it gets far less attention than the report design does. Providers that publish validation of their full collection and transport workflow, rather than only their sequencing accuracy, are answering a question that changes what your result means. Our page on whether gut health tests are accurate covers what to ask each provider and which ones publish the work.
Who Should Skip a Microbiome Test Here
Three groups get little from a microbiome test bought for menopause reasons.
- Anyone with symptoms that are affecting daily life. Hot flushes disrupting sleep, genitourinary symptoms, or mood changes that are hard to manage all have treatment options with trial evidence behind them. A test that describes bacteria delays that conversation by several weeks and does not inform it.
- Anyone deciding about hormone therapy. Prescribing guidance rests on your symptoms, age, time since your last period, and medical and family history, as the Eunice Kennedy Shriver National Institute of Child Health and Human Development sets out. Microbiome composition appears nowhere in it. Our guide to hormone therapy options covers what that appointment actually turns on.
- Anyone expecting a repeatable number to track. Gut composition moves with recent meals, travel, illness and antibiotics, so two samples weeks apart can differ substantially without anything meaningful having changed.
Our position here would change on one specific result. A randomised trial showing that women who acted on a consumer microbiome report had better symptom outcomes than women receiving standard care would move stool sequencing from description to guidance. We would revise our position the week it published. Trials testing named probiotic strains against defined menopause symptoms are the nearer-term thing to watch, since strain-level evidence is where this field is currently producing results.
A useful sequence exists for acting on the gut microbiome and menopause connection today. Start with a symptom discussion with a clinician, add a hormone panel if the transition stage is unclear, and order a vaginal swab only if genitourinary symptoms are the specific problem you want investigated.
Frequently Asked Questions
Does menopause change your gut microbiome?
Comparison studies find that gut bacterial composition differs between premenopausal and postmenopausal groups, so the association is real at the population level. What remains unresolved is how much of that difference menopause itself produces. Age, medication use, dietary change and shifts in body composition all move alongside the menopause transition and all independently affect gut bacteria. The vaginal microbiome is a clearer case: estrogen decline changes it through a well understood mechanism, and that change is part of routine menopause medicine.
What is the estrobolome?
The estrobolome is the collection of gut bacteria carrying genes that act on estrogen. The mechanism is straightforward biochemistry. Your liver packages used estrogen for disposal by attaching a molecule to it, and certain gut bacteria produce beta-glucuronidase, an enzyme that strips that packaging off. Freed estrogen can then be reabsorbed from the gut rather than excreted. The biochemistry is not in dispute. What no consumer test currently does is turn a bacterial composition report into a number telling you how much estrogen you are recirculating.
Can a microbiome test help with menopause symptoms?
Not in the way the marketing implies. No published trial shows that acting on a consumer microbiome report improves hot flushes, sleep disruption, mood symptoms or genitourinary symptoms compared with standard care. A stool test returns a description of your bacteria at one moment, not a treatment plan with evidence behind it. If symptoms are the reason you are considering a test, a conversation with a clinician about the treatments that do have trial evidence is a better use of both the money and the time.
Why does vaginal pH rise after menopause?
Estrogen maintains glycogen in the cells lining the vaginal tract, and Lactobacillus species feed on that glycogen and produce lactic acid, which holds pH low. As estrogen falls, glycogen falls, lactobacilli lose their food source and their numbers drop, so less lactic acid is produced and pH rises. This is one of the better understood microbiome changes in medicine, and it underlies the genitourinary symptoms many women report during and after the transition. Treatment options for those symptoms are a clinical discussion with your own physician.
Should I take a probiotic during menopause?
That depends on the specific product and what you want it to do, which is a question for your clinician rather than a general recommendation. Probiotic evidence is strain-specific: a trial result for one named strain at one dose does not transfer to a different product containing a different strain. Several vaginal-health strains have their own trial literature that is separate from general gut probiotics. The practical implication is that a product is worth judging on the evidence for its own strains, not on whether probiotics as a category sound reasonable.
Is a vaginal microbiome test more useful than a stool test here?
For menopause specifically, yes. The vaginal microbiome shift has an understood mechanism, a measurable marker in Lactobacillus dominance, and a direct link to symptoms clinicians already treat. Gut microbiome reports are broader and much harder to act on, because the link between a composition score and any menopause symptom is not established. Neither test diagnoses anything, and a swab result still needs a clinician to connect it to what you are experiencing.
Do I need a microbiome test before starting hormone therapy?
No. Decisions about hormone therapy are made on your symptoms, your medical and family history, your age and time since your last period, and your own risk factors. Microbiome composition is not part of any published prescribing guidance. If you are weighing hormone therapy, the discussion that matters is with a clinician who knows your history, and our guide to hormone therapy options covers the questions worth raising in that appointment.
How reliable are at-home microbiome tests?
The sequencing itself is reliable at identifying which bacteria are present. The weaknesses sit either side of it. Sample handling before the laboratory receives it affects the result, because bacterial populations continue changing in a container, and no amount of sequencing accuracy corrects a sample that shifted in transit. On the other side, the interpretation layer that turns raw composition into scores and food recommendations is proprietary to each company and mostly unvalidated against outcomes. Our page on gut test accuracy covers both problems in detail.
Related
- Women's health hub: the full guide index
- Perimenopause biomarker panel: which markers are readable
- The three stages of menopause
- Perimenopause symptoms
- Hormone therapy options
- Are gut health tests accurate
- Best gut health test: providers compared